Jason R. Klug

Jason R. Klug

Auto-generated profile, based on publicly available information

Jason R. Klug

Division of Radiology, Mayo Clinic, Rochester, MN, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in eLife
Verified
Journal Article
Open access
JKJason R Klug
Jason R Klug
MEMax D Engelhardt
Max D Engelhardt
CCCara N Cadman
Cara N Cadman
HLHao Li
Hao Li
JSJared Smith
Jared Smith
XJXin Jin
Xin Jin
Striatal cholinergic (ChAT) and parvalbumin (PV) interneurons exert powerful influences on striatal function in health and disease, yet little is known about the organization of their inputs. Here using rabies tracing, electrophysiology and genetic tools, we compare the whole-brain inputs to these two types of striatal interneurons and dissect their functional connectivity in mice. ChAT interneurons receive a substantial cortical input from associative regions of cortex, such as the orbitofrontal cortex. Amongst subcortical inputs, a previously unknown inhibitory thalamic reticular nucleus input to striatal PV interneurons is identified. Additionally, the external segment of the globus pallidus targets striatal ChAT interneurons, which is sufficient to inhibit tonic ChAT interneuron firing. Finally, we describe a novel excitatory pathway from the pedunculopontine nucleus that innervates ChAT interneurons. These results establish the brain-wide direct inputs of two major types of striatal interneurons and allude to distinct roles in regulating striatal activity and controlling behavior.

13 March 2025 in Journal of Hepatology
Verified
Journal Article
Closed access
ELEllen L. Larson
Ellen L. Larson
SESamia D. Ellias
Samia D. Ellias
DBDaniel J. Blezek
Daniel J. Blezek
JKJason Klug
Jason Klug
RHRobert P. Hartman
Robert P. Hartman
JHJulie K. Heimbach
Julie K. Heimbach

22 March 2025 in Digestive and Liver Disease
Verified
Journal Article
Closed access
PCPedro Cortés
Pedro Cortés
TMTyler A. Mistretta
Tyler A. Mistretta
BJBrittany Jackson
Brittany Jackson
COCaroline G. Olson
Caroline G. Olson
AQAhmed M. Al Qady
Ahmed M. Al Qady
YBYan Bi
Yan Bi

15 June 2022 in Cancer Research
Verified
Journal Article
Open access
GBGehan Botrus
Gehan Botrus
Pedro Luiz Serrano Uson JuniorPedro Luiz Serrano Uson Junior
Pedro Luiz Serrano Uson Junior
HKHeidi Kosiorek
Heidi Kosiorek
MAMehmet Akce
Mehmet Akce
ICIsabela Chang
Isabela Chang
TBTanios Bekaii-Saab
Tanios Bekaii-Saab
Background: Sarcopenia is one of the early pathological features of cancer cachexia, yet the effect of sarcopenia on clinical outcomes in patients with advanced HCC is unclear. Our objective was to determine the effect of Sarcopenia on response to systemic therapy with advanced HCC. Methods: Patients with unresectable and advanced liver cancer were retrospectively evaluated between 2010 to 2019. Skeletal muscle area (SMA) was computed with a previously validated computed tomography (CT) body composition AI algorithm. The skeletal muscle index (SMI) was derived from the skeletal muscle area (SMA) (cm2) divided by patient height (m2) calculated from images at the level of L3 on pretreatment CT. Sarcopenia cutoffs for females was less than 39 cm2/m2 SMI or less than 50 cm2/m2 SMI for males. Patients’ demographics, systemic treatment response, toxicity, progression-free survival (PFS) and overall survival (OS) were compared between first-line therapy groups. Kaplan-Meier and Cox proportional hazards regression were used for survival analysis comparisons. Results: A total of 146 patients with advanced HCC were assessed from Mayo Clinic Arizona and Emory University. Seventy-six patients received immunotherapy as first-line treatment and seventy patients received TKI as first-line therapy. Sarcopenia at baseline was assessed in a total of 91 patients at first-line systemic treatment: n=48 with immunotherapy (IO) and n=43 with tyrosine kinase inhibitor (TKI). Sarcopenia was more prevalent in male patients (p=0.009), and in patients with low BMI (p=0.02). When comparing those with sarcopenia at baseline, higher response rate was observed in patients treated with IO without sarcopenia (47% versus 15%, p=0.019), this was not observed in TKI group. Interestingly, median PFS and OS was not significantly changed in patients with or without sarcopenia treated with IO or TKI on first-line therapy. Conclusions: Sarcopenia was associated with reduced response rate (RR) in patients treated with IO, but not in TKI groups. Both didn’t translate into deleterious effect in PFS and or OS. Further research with sufficient adjustments for confounding factors is warranted to better elucidate the prognostic value of sarcopenia in these patients. Citation Format: Gehan Botrus, Pedro Luiz Serrano Uson Junior, Heidi Kosiorek, Mehmet Akce, Isabela Chang, Zhubene Mesbah, Eric Yancey, Daniel Blezek, Jason Klug, Lana Khalil, Puneet Raman, Mohamad Sonbol, Mitesh Borad, Daniel Ahn, Tanios Bekaii-Saab. Prognostic impact of Sarcopenia on clinical outcomes in advanced hepatocellular carcinoma (HCC) treated with systemic therapy [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 6274.

9 November 2022 in arXiv
Verified
Preprint
Open access
PDF file
DWDarryl E. Wright
Darryl E. Wright
CCCole Cook
Cole Cook
JKJason Klug
Jason Klug
PKPanagiotis Korfiatis
Panagiotis Korfiatis
TKTimothy L. Kline
Timothy L. Kline
The de facto standard of dynamic histogram binning for radiomic feature extraction leads to an elevated sensitivity to fluctuations in annotated regions. This may impact the majority of radiomic studies published recently and contribute to issues regarding poor reproducibility of radiomic-based machine learning that has led to significant efforts for data harmonization; however, we believe the issues highlighted here are comparatively neglected, but often remedied by choosing static binning. The field of radiomics has improved through the development of community standards and open-source libraries such as PyRadiomics. But differences in image acquisition, systematic differences between observers' annotations, and preprocessing steps still pose challenges. These can change the distribution of voxels altering extracted features and can be exacerbated with dynamic binning.